nach oben

Erschienen in:

01.04.2016 | Original Article

Weight loss with mindful eating in African American women following treatment for breast cancer: a longitudinal study

verfasst von: SeonYoon Chung, Shijun Zhu, Erika Friedmann, Catherine Kelleher, Adriane Kozlovsky, Karen W. Macfarlane, Katherine H. R. Tkaczuk, Alice S. Ryan, Kathleen A. Griffith

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Women with higher body mass index (BMI) following breast cancer (BC) treatment are at higher risk of BC recurrence and death than women of normal weight. African American (AA) BC patients have the highest risk of BC recurrence and gain more weight after diagnosis than their white counterparts. The purpose of this study was to evaluate the association between a mindful eating intervention and weight loss in AA women following chemotherapy for BC.

Methods

A single-group 24-week longitudinal pilot study with repeated measures was conducted. AA women (N = 22, BMI = 35.13 kg/m², range = 27.08–47.21) with stage I–III BC who had finished active cancer treatment received a 12-week mindful eating intervention with individual dietary counseling and group mindfulness sessions, followed by bi-weekly telephone follow-up for 12 weeks. Linear mixed models were used to evaluate the effects of the intervention and of baseline mindfulness on the weight change over time.

Results

In the overall group (N = 22), MEQ scores increased over time (p = 0.001) while weight decreased over time (−0.887 kg, p = 0.015). Weight loss over time was associated with higher T1 MEQ scores (p = 0.043). Participants in the higher MEQ group (n = 11) at T1 experienced significant weight loss over time (−1.166 kg, p = 0.044), whereas those in the low MEQ (n = 11) did not lose weight. Participants who were diagnosed with stage 1 BC experienced significant weight loss over time (−7.909 kg, p = 0.014).

Conclusions

This study suggests that a mindful weight loss program may be effective for weight reduction and maintenance in some AA women who have completed treatment for BC, particularly those diagnosed with stage 1 BC and with initially higher mindful eating behaviors. Mindful weight loss program is proposed as a promising way in which to reduce obesity-related conditions in AA BC survivors.

Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW (1981) Body weight and prognosis in breast cancer. J Natl Cancer Inst 67(4):785–789PubMed

Chlebowski BRT, Aiello E, Mctiernan A (2014) Weight loss in breast cancer patient management. J Clin Oncol 20(4):1128–1143CrossRef

Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20(1):42–51CrossRefPubMed

Irwin ML, McTiernan A, Baumgartner RN et al (2005) Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 23(4):774–782. doi:10.1200/JCO.2005.04.036 PubMedCentralCrossRefPubMed

Druesne-Pecollo N, Touvier M, Barrandon E et al (2012) Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat 135(3):647–654. doi:10.1007/s10549-012-2187-1 CrossRefPubMed

Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635. doi:10.1007/s10549-010-0990-0 CrossRefPubMed

Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370–1378. doi:10.1200/JCO.2005.01.079 CrossRefPubMed

Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12(4):282–294. doi:10.1111/j.1467-789X.2010.00805.x CrossRefPubMed

Rock CL, Flatt SW, Newman V et al (1999) Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99(10):1212–1221CrossRefPubMed

10.

Kabat-Zinn J (2003) Mindfulness-based interventions in context: past, present, and future. Clin Psychol Sci Pract 10:144–156CrossRef

11.

Godsey J (2013) The role of mindfulness based interventions in the treatment of obesity and eating disorders: an integrative review. Complement Ther Med 21(4):430–439. doi:10.1016/j.ctim.2013.06.003 CrossRefPubMed

12.

Katterman SN, Kleinman BM, Hood MM, Nackers LM, Corsica J (2014) Mindfulness meditation as an intervention for binge eating, emotional eating, and weight loss: a systematic review. Eat Behav 15(2):197–204. doi:10.1016/j.eatbeh.2014.01.005 CrossRefPubMed

13.

O’Reilly GA, Cook L, Spruijt-Metz D, Black DS (2014) Mindfulness-based interventions for obesity-related eating behaviours: a literature review. Obes Rev 15(6):453–461. doi:10.1111/obr.12156 PubMedCentralCrossRefPubMed

14.

Woods-Giscombé CL, Gaylord SA (2014) The cultural relevance of mindfulness meditation as a health intervention for African Americans: implications for reducing stress-related health disparities. J Holist Nurs 32(3):147–160. doi:10.1177/0898010113519010 CrossRefPubMed

15.

Carlson LE, Speca M, Faris P, Patel KD (2007) One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 21(8):1038–1049. doi:10.1016/j.bbi.2007.04.002 CrossRefPubMed

16.

Witek-Janusek L, Albuquerque K, Chroniak KR, Chroniak C, Durazo-Arvizu R, Mathews HL (2008) Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav Immun 22(6):969–981. doi:10.1016/j.bbi.2008.01.012 PubMedCentralCrossRefPubMed

17.

Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hébert JR (2012) The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat 131(1):99–109. doi:10.1007/s10549-011-1738-1 PubMedCentralCrossRefPubMed

18.

Academy of Nutrition and Dietetics Evidence Analysis Library (2015) Adult weight management reduced calorie diets-recommendations. Available at: http://www.andeal.org/template.cfm?template=guide_summary&key=622&highlight=Adult weight management evidence%2Dbased&home = 1. Accessed 2 June , 2015

19.

Griffith KA, Royak-Schaler R, Nesbitt K et al (2012) A culturally specific dietary plan to manage weight gain among African American breast cancer survivors: a feasibility study. Nutr Health 21(2):97–105. doi:10.1177/0260106012459938 PubMedCentralCrossRefPubMed

20.

Framson C, Kristal AR, Schenk JM, Littman AJ, Zeliadt S, Benitez D (2009) Development and validation of the mindful eating questionnaire. J Am Diet Assoc 109(8):1439–1444. doi:10.1016/j.jada.2009.05.006 PubMedCentralCrossRefPubMed

21.

Pockaj B, AC D, Boughey JC, Gray RJ, McLaughlin S, Dueck AC, Perez E, Halyard MY, Frost MH, Cheville AL, Ja S (2009) Quality of life after breast cancer surgery: what have we learned and where should we go next? J Surg Oncol 99:447–455CrossRefPubMed

22.

Blixen CE, Singh A, Thacker H (2006) Values and beliefs about obesity and weight reduction among African American and Caucasian women. J Transcult Nurs 17(3):290–297. doi:10.1177/1043659606288375 CrossRefPubMed

23.

Stolley MR, Sharp LK, Oh A, Schiffer L (2009) A weight loss intervention for African American breast cancer survivors, 2006. Prev Chronic Dis 6:A22PubMedCentralPubMed

24.

Wilson DB, Porter JS, Parker G, Kilpatrick J (2005) Anthropometric changes using a walking intervention in African American breast cancer survivors: a pilot study. Prev Chronic Dis 2:A16PubMedCentralPubMed

25.

Tapper K, Shaw C, Ilsley J, Hill AJ, Bond FW, Moore L (2009) Exploratory randomised controlled trial of a mindfulness-based weight loss intervention for women. Appetite 52(2):396–404. doi:10.1016/j.appet.2008.11.012 CrossRefPubMed

26.

Lillis J, Hayes SC, Bunting K, Masuda A (2009) Teaching acceptance and mindfulness to improve the lives of the obese: a preliminary test of a theoretical model. Ann Behav Med 37(1):58–69. doi:10.1007/s12160-009-9083-x CrossRefPubMed

27.

Paolini B, Burdette JH, Laurienti PJ, Morgan AR, Williamson DA, Rejeski WJ (2012) Coping with brief periods of food restriction: mindfulness matters. Front Aging Neurosci 4(June):13. doi:10.3389/fnagi.2012.00013 PubMedCentralPubMed

Titel: Weight loss with mindful eating in African American women following treatment for breast cancer: a longitudinal study
verfasst von: SeonYoon Chung
Shijun Zhu
Erika Friedmann
Catherine Kelleher
Adriane Kozlovsky
Karen W. Macfarlane
Katherine H. R. Tkaczuk
Alice S. Ryan
Kathleen A. Griffith
Publikationsdatum: 01.04.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 4/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-015-2984-2

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Weight loss with mindful eating in African American women following treatment for breast cancer: a longitudinal study